Hormone induced chromosomal instability in p53-null mammary epithelium

Cancer Research

Volumn 64, Issue 16, 2004, Pages 5608-5616

  Pati, Debananda ^a   Haddad, Bassem R ^c   Haegele, Albert ^f   Thompson, Henry ^f   Kittrell, Frances S ^b   Shepard, Anne ^b   Montagna, Cristina ^d   Zhang, Nenggang ^a   Ge, Gouqing ^a   Otta, Subhendu Kumar ^a   McCarthy, Maureen ^e   Ullrich, Robert L ^g   Medina, Daniel ^b  

^a TEXAS CHILDREN S CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DNA; ENZYME; PROTEIN MAD2; PROTEIN P53; PROTEIN RAD1; PROTEIN RAD21; RNA; SECURIN; SEPARASE; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL CYCLE G2 PHASE; CELL STRAIN MCF 7; CHROMOSOMAL INSTABILITY; CHROMOSOME 2; CHROMOSOME DISORDER; CHROMOSOME SEGREGATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DNA SYNTHESIS; GENE AMPLIFICATION; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOGENESIS; MITOSIS SPINDLE; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SISTER CHROMATID; STEROID HORMONE RESPONSE ELEMENT; WESTERN BLOTTING;

NON-PROGRAMMATIC;

ANEUPLOIDY; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; ENDOPEPTIDASES; EPITHELIAL CELLS; ESTROGENS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; PROGESTERONE; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4143100480     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0629     Document Type: Article

References (50)

1. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science (Wash DC) 1996;271:1744-7.
2. Tarapore P, Fukasawa K. p53 mutation and mitotic infidelity. Cancer Investig 2000;18:148-55.
3. Chiba S, Okuda M, Mussman JG, Fukasawa K. Genomic convergence and suppression of centrosome hyperamplification in primary p53-/- cells in prolonged culture. Exp Cell Res 2000;258:310-21.
4. Donehower LA, Godley LA, Aldaz CM, et al. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 1995;9:882-95.
5. Shao C, Deng L, Henegariu O, et al. Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc Natl Acad Sci USA 2000;97:7405-10.
6. Bunz F, Fauth C, Speicher MR, et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 2002;62:1129-33.
7. Lu X, Magrane G, Yin C, et al. Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol Cell Biol 2001;21:6017-30.
8. Goepfert TM, McCarthy M, Kittrell FS, et al. Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J 2000;14:2221-9.
9. Auer GU, Heselmeyer KM, Steinbeck RG, Munck-Wikland E, Zetterberg AD. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Arch 1994;424:343-7.
10. Campomenosi P, Assereto P, Bogliolo M, et al. p53 mutations and DNA ploidy in colorectal adenocarcinomas. Anal Cell Pathol 1998;17:1-12.
11. Duesberg P, Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskeleton 2000;47:81-107.
12. Duesberg P, Li R, Rasnick D, et al. Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet Cytogenet 2000;119:83-93.
13. Li JJ, Papa D, Davis JF, et al. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 2002;33:56-65.
14. Li JJ, Li SA. Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer. Adv Exp Med Biol 2003;532:195-207.
15. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci USA 2000;97:3236-41.
16. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 2001;61:8838-44.
17. Nasmyth K. Segregating sister genomes: The molecular biology of chromosome separation. Science (Wash DC) 2002;297:559-65.
18. Lingle WL, Barrett SL, Negron VC, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 2002;99:1978-83.
19. Pihan GA, Doxsey SJ. The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol 1999;9:289-302.
20. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001;1:109-17.
21. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000;27:75-93.
22. Liehr JG. Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 2001;7:273-81.
23. Jerry DJ, Kittrell FS, Kuperwasser C, et al. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 2000;19:1052-8.
24. Kuperwasser C, Hurlburt GD, Kittrell FS, et al. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. Am J Pathol 2000;157:2151-9.
25. Medina D, Kittrell FS, Shepard A, et al. Biological and genetic properties of the p53 null preneoplastic mammary epithelium. FASEB J 2002;16:881-3.
26. Jerry DJ, Kuperwasser C, Downing SR, et al. Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene 1998;17:2305-12.
27. Aldaz CM, Hu Y, Daniel R, et al. Serial analysis of gene expression in normal p53 null mammary epithelium. Oncogene 2002;21:6366-76.
28. Christon K, Swanson SM, Guzman RC, et al. Kinetics of mammary epithelial cell proliferation in pituitary isografted BALB/c mice. Carcinogenesis (Lond) 1993;14:2019-25.
29. Said TK, Conneely O, Medina D, O'Malley B, Lydon J. Progesterone in addition to estrogen induces cyclin D1 expression in mammary epithelial cells in vivo. J Endocrinol 1997;138:3933-9.
30. Murphy K, Kittrell FS, Gay J, et al. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene 1999;18:6597-604.
31. -/- mice and genome stabilization in immortalized cells by reintroduction of PARP cDNA. Proc Natl Acad Sci USA 1999;96:13191-6.
32. Figueiredo BC, Stratakis CA, Sandrini R, et al. Comparative genomic hybridization (CGH) analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 1999;84:1116-21.
33. Pati D, Zhang N, Plon SE. Linking sister chromatid cohesion and apoptosis: role of Rad 21. Mol Cell Biol 2002;22:8267-77.
34. Medina D, Kittrell FS. Establishment of mouse mammary cell lines. In: Ip MM, Asch BB, editors. Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic Press; 2000. p. 137-45.
35. Quandt K, Frech K, Karas H, Wingender E, Wemer T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84.
36. Medina D, Kittrell FS, Shepard A, et al. Hormone dependence in premalignant mammary progression. Cancer Res 2003;63:1067-72.
37. Wong J, Li PX, Klamut HJ. A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53. J Biol Chem 2002;277:26699-707.
38. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature (Lond) 1997;386:623-7.
39. Reese J, Das SK, Paria BC, et al. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem 2001;276:44137-45.
40. Waizenegger IC, Hauf S, Meinke A, Peters JM. Two distinct pathways remove mammalian cohesion from chromosome arms in prophase and from centromeres in anaphase. Cell 2000;103:399-410.
41. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-93.
42. Michel LS, Liberal V, Chatterjee A, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature (Lond) 2001;409:355-9.
43. Chung E, Chen RH. Spindle checkpoint requires mad1-bound and mad1-free mad2. Mol Biol Cell 2002;13:1501-11.
44. O'Neill TJ, Zhu Y, Gustafson TA. Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation. J Biol Chem 1997;272:10035-40.
45. Poelzl G, Kasai Y, Mochizuki N, et al. Specific association of estrogen receptor beta with the cell cycle spindle assembly check-point protein, MAD2. Proc Natl Acad Sci USA 2000;97:2836-9.
46. Takeda M, Dohmae N, Takio K, Arai K, Watanabe S. Cell cycle-dependent interaction of Mad2 with conserved Box1/2 region of human granulocyte-macrophage colony-stimulating factor receptor common betac. J Biol Chem 2001;276:41803-9.
47. Tanaka K, Nishioka J, Kato K, et al. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn J Cancer Res 2001;92:952-8.
48. Wang X, Jin D-Y, Ng RWM, et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 2002;62:1662-8.
49. Asch BB. Tumor viruses and endogenous retrotransposons in mammary tumorigenesis. J Mammary Gland Biol Neoplasia 1996;1:49-60.
50. Van Houten JN, Asch HL, Asch BB. Cloning and characterization of ectopically expressed transcripts from actin-binding protein MIPP in mouse mammary carcinomas. Oncogene 2001;40:5366-72.